Before committing to a treatment, it is worth understanding what these medications do and the nutritional gaps they create
Foto: SVT/Jennifer Alm, AP/TT Andreea Alexandru.Mer om programmet Det sprids vldsamt innehll i onlinespel och chattkanaler som kan radikalisera unga mnniskor
Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake
Something to keep on your radar
Seefeldt T, Dwivedi C, Peitz G, Herman J, Carlson L, Zhang Z, et al